ACC GmbH Analytical Clinical Concepts
ACC GmbH Analytical Clinical Concepts is recorded as a service provider in 6 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 6 of 6 trials · Latest update first
Double-blind, double-dummy, randomized, parallel-group, non-inferiority phase III trial on the efficacy and tolerability of 2 mg once daily vs. 1 mg twice daily budesonide orodispersible tablets for induction of histological remission in adults with eosinophilic esophagitis
Sponsor Dr. Falk Pharma GmbH
- Start (EU)
- Latest update
- Estimated end
A Randomized, Open label, Single Center, Single Oral Dose, Four Treatment, Four Period, Four Sequence, Crossover Bioavailability Study of Haleon Immediate Release Tablets 2X (paracetamol/naproxen 500 mg/125 mg) vs. Panadol Advance Tablets 2X (paracetamol 500 mg), Naprosyn Tablets 1X (naproxen 250 mg), administered individually in fasted conditions and Haleon Immediate Release Tablets 2X (paracetamol/naproxen 500 mg/125 mg) in fed conditions in Healthy Adult Participants
Sponsor Haleon CH SARL
- Start (EU)
- Latest update
- Estimated end
- Not reported
A single-centre, open-label, randomised, phase II study on the maintenance of ovulation inhibition after intentional application errors during 84 days of treatment with MR-130A-01 contraceptive transdermal patch
Sponsor Mylan Pharmaceuticals Inc.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Investigation of 3 different doses of a newly developed vaginal ring releasing estriol for the treatment of vaginal atrophy - a placebo-controlled, double-blind, combined dose-finding and proof-of-concept trial with parallel-group design in postmenopausal women
Sponsor SocraTec R&D Concepts in Drug Research and Development GmbH
- Start (EU)
- Latest update
- Estimated end
- Not reported
A mono-centre, non-comparative clinical trial on the inhibition of ovulation with LNG POP (Levonorgestrel tablet, 0.135 mg) during three 28-day cycles with continuous treatment and intentional intake errors
Sponsor SocraTec R&D Concepts in Drug Research and Development GmbH
- Start (EU)
- Latest update
- Estimated end
- Not reported
A randomized, double-blind, single-center, 2-period cross-over Phase I study to assess the tolerability, safety and pharmacokinetics of antidepressant doses of oral ketamine hydrochloride prolonged release tablets (KET01) compared to intranasal esketamine in healthy male subjects
Sponsor Ketabon GmbH
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for ACC GmbH Analytical Clinical Concepts?
The 2026-10-09 snapshot links ACC GmbH Analytical Clinical Concepts to 6 distinct CTIS trials. Recorded services include Laboratory services, bioanalytical analysis, Bioanalytics, Pharmacokinetic analysis. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for ACC GmbH Analytical Clinical Concepts?
The most frequently recorded therapeutic areas are Gastroenterology, Other. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to ACC GmbH Analytical Clinical Concepts conducted?
The linked trials record locations in 4 countries, including Germany, Austria, Spain, Portugal. These are trial locations, not confirmed office locations or countries where ACC GmbH Analytical Clinical Concepts delivered services.
What can this page tell me about ACC GmbH Analytical Clinical Concepts's trial experience?
Browse 6 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under ACC GmbH Analytical Clinical Concepts. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- ACC GmbH Analytical Clinical Concepts